Your browser is too old
We can't provide a great video experience on old browserUpdate now
Vulval Intraepithelial Neoplasia (VIN)
In this lecture ´´Premalignant Diseases´´ are explained. Section one is about ´´Vulval Intraepithelial Neoplasia (VIN)´´. At first educator introduces vulval intraepithelial neoplasia (VIN). Then Diagnosis is carried out. Furthermore, histology of VIN is observed. After that methods of surgery are explained. Lastly, Paget’s disease is discussed.
Vaginal Intraepithelial Neoplasia (VAIN)
Section two is about ‘’Vaginal Intraepithelial Neoplasia (VAIN)’’. Initially, educator tells that etiologic agent of vaginal intraepithelial neoplasia is oncogenic HPV. After that pathology is discussed. Then diagnosis is carried out. Subsequently, its management method is pursued.
Cervical Intraepithelial Neoplasia (CIN)
Section three is about ‘’Cervical Intraepithelial Neoplasia (CIN)’’. In the very first slide of this section cervical intraepithelial neoplasia (CIN) is introduced. Next is the explanation of continuum of changes from reserve cell hyperplasia. Then pathogenesis of CIN and invasive carcinoma is discussed. Moving onward, disease progression of CIN is highlighted. Afterwards, risk factors for CIN and cervical cancer are reported. Lastly, life cycle of unstable cervical epithelium is presented.
Human Papiloma Virus (HPV)
Section four is about ‘’Human Papilloma Virus (HPV)’’. Educator gives an overview of human papilloma virus (HPV) and discuss its pathology. After that diagnosis of CIN is explained. Then abnormal colposcopic findings are reported. Next focus is the diagnostic conization. Moreover, information is revealed about treatment of CIN. It includes preventive treatment and definitive treatment. Furthermore, ablation of the local lesion is highlighted. Subsequently, large loop excision of the transformation zone (LLETZ) is pursued. In the end, hysterectomy is explained.
Premalignant Endometrial Lesion
Section five is about ‘’Premalignant Endometrial Lesion’’. Educator explains premalignant endometrial lesion along with risk factors and protective factors. This is followed by histology. After that management is focused which include elucidation of preventive treatment and definitive treatment.